Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
6.60
+0.97 (17.23%)
At close: May 15, 2025, 4:00 PM
6.66
+0.06 (0.91%)
After-hours: May 15, 2025, 7:51 PM EDT

Fulcrum Therapeutics Market Cap

Fulcrum Therapeutics has a market cap or net worth of $356.26 million as of May 15, 2025. Its market cap has decreased by -19.04% in one year.

Market Cap
356.26M
Enterprise Value
137.77M
1-Year Change
-19.04%
Ranking
Category
Stock Price
$6.60

Market Cap Chart

Since July 18, 2019, Fulcrum Therapeutics's market cap has increased from $301.64M to $356.26M, an increase of 18.11%. That is a compound annual growth rate of 2.90%.

History

DateMarket Cap% Change
May 14, 2025303.90M19.88%
Dec 31, 2024253.51M-39.25%
Dec 29, 2023417.30M10.13%
Dec 30, 2022378.93M-47.15%
Dec 31, 2021716.95M124.42%
Dec 31, 2020319.46M-14.89%
Dec 31, 2019 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 645.01B
Johnson & Johnson 357.95B
AbbVie 313.89B
Novo Nordisk 288.64B
UnitedHealth Group 237.25B
Abbott Laboratories 229.73B
Novartis AG 208.47B
AstraZeneca 206.71B
Market Cap Rankings